{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:27:43Z","timestamp":1794554863921,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2020J01631"],"award-info":[{"award-number":["2020J01631"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2021J02034"],"award-info":[{"award-number":["2021J02034"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Funds for the innovation of science and Technology of Fujian province","award":["2018Y9076"],"award-info":[{"award-number":["2018Y9076"]}]},{"name":"Joint Funds for the innovation of science and Technology of Fujian province","award":["2021Y9009"],"award-info":[{"award-number":["2021Y9009"]}]},{"DOI":"10.13039\/501100012336","name":"Major State Basic Research Development Program of China","doi-asserted-by":"publisher","award":["2017YFA0205201"],"award-info":[{"award-number":["2017YFA0205201"]}],"id":[{"id":"10.13039\/501100012336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81925019"],"award-info":[{"award-number":["81925019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22074017"],"award-info":[{"award-number":["22074017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1705281"],"award-info":[{"award-number":["U1705281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Research Fund of Key Laboratory of Nanomedical Technology of Fujian Medical University","award":["2022KLNT202"],"award-info":[{"award-number":["2022KLNT202"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The combination of drug delivery with immune checkpoint targeting has been extensively studied in cancer therapy. However, the clinical benefit for patients from this strategy is still limited. B7 homolog 3 protein (B7-H3), also known as CD276 (B7-H3\/CD276), is a promising therapeutic target for anti-cancer treatment. It is widely overexpressed on the surface of malignant cells and tumor vasculature, and its overexpression is associated with poor prognosis. Herein, we report B7H3 targeting doxorubicin (Dox)-conjugated gold nanocages (B7H3\/Dox@GNCs) with pH-responsive drug release as a selective, precise, and synergistic chemotherapy-photothermal therapy agent against non-small-cell lung cancer (NSCLC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In vitro, B7H3\/Dox@GNCs exhibited a responsive release of Dox in the tumor acidic microenvironment. We also demonstrated enhanced intracellular uptake, induced cell cycle arrest, and increased apoptosis in B7H3 overexpressing NSCLC cells. In xenograft tumor models, B7H3\/Dox@GNCs exhibited tumor tissue targeting and sustained drug release in response to the acidic environment. Wherein they synchronously destroyed B7H3 positive tumor cells, tumor-associated vasculature, and stromal fibroblasts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study presents a dual-compartment targeted B7H3 multifunctional gold conjugate system that can precisely control Dox exposure in a spatio-temporal manner without evident toxicity and suggests a general strategy for synergistic therapy against NSCLC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12951-023-02078-9","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T10:02:17Z","timestamp":1697536937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC"],"prefix":"10.1186","volume":"21","author":[{"given":"Bing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaifan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengchao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyang","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizhen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"2078_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"2078_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N, Chen W. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135:584\u201390.","journal-title":"Chin Med J"},{"key":"2078_CR3","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/s41467-021-22801-0","volume":"12","author":"F Wu","year":"2021","unstructured":"Wu F, Fan J, He Y, Xiong A, Yu J, Li Y, Zhang Y, Zhao W, Zhou F, Li W, et al. Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer. Nat Commun. 2021;12:2540.","journal-title":"Nat Commun"},{"key":"2078_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","volume":"164","author":"CT Hensley","year":"2016","unstructured":"Hensley CT, Faubert B, Yuan Q, Lev-Cohain N, Jin E, Kim J, Jiang L, Ko B, Skelton R, Loudat L, et al. Metabolic heterogeneity in human lung tumors. Cell. 2016;164:681\u201394.","journal-title":"Cell"},{"key":"2078_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446\u201354.","journal-title":"Nature"},{"key":"2078_CR6","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.biotechadv.2013.10.002","volume":"32","author":"S Guo","year":"2014","unstructured":"Guo S, Huang L. Nanoparticles containing insoluble drug for cancer therapy. Biotechnol Adv. 2014;32:778\u201388.","journal-title":"Biotechnol Adv"},{"key":"2078_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jconrel.2021.07.014","volume":"337","author":"S Ghosh","year":"2021","unstructured":"Ghosh S, Javia A, Shetty S, Bardoliwala D, Maiti K, Banerjee S, Khopade A, Misra A, Sawant K, Bhowmick S. Triple negative breast cancer and non-small cell lung cancer: clinical challenges and nano-formulation approaches. J Control Release. 2021;337:27\u201358.","journal-title":"J Control Release"},{"key":"2078_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.7150\/thno.17099","volume":"7","author":"D Zhang","year":"2017","unstructured":"Zhang D, Zheng A, Li J, Wu M, Wu L, Wei Z, Liao N, Zhang X, Cai Z, Yang H, et al. Smart Cu(II)-aptamer complexes based gold nanoplatform for tumor micro-environment triggered programmable intracellular prodrug release, photodynamic treatment and aggregation induced photothermal therapy of hepatocellular carcinoma. Theranostics. 2017;7:164\u201379.","journal-title":"Theranostics"},{"key":"2078_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrc.2017.84","volume":"17","author":"J Rotow","year":"2017","unstructured":"Rotow J, Bivona TG. Understanding and targeting resistance mechanisms in NSCLC. Nat Rev Cancer. 2017;17:637\u201358.","journal-title":"Nat Rev Cancer"},{"key":"2078_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-med-062315-120245","volume":"68","author":"K Newick","year":"2017","unstructured":"Newick K, O\u2019Brien S, Moon E, Albelda SM. CAR T cell therapy for solid tumors. Annu Rev Med. 2017;68:139\u201352.","journal-title":"Annu Rev Med"},{"key":"2078_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12951-021-01198-4","volume":"20","author":"P Zanjanchi","year":"2022","unstructured":"Zanjanchi P, Asghari SM, Mohabatkar H, Shourian M, Shafiee Ardestani M. Conjugation of VEGFR1\/R2-targeting peptide with gold nanoparticles to enhance antiangiogenic and antitumoral activity. J Nanobiotechnol. 2022;20:7.","journal-title":"J Nanobiotechnol"},{"key":"2078_CR12","doi-asserted-by":"publisher","first-page":"701006","DOI":"10.3389\/fimmu.2021.701006","volume":"12","author":"WT Zhou","year":"2021","unstructured":"Zhou WT, Jin WL. B7\u2013H3\/CD276: an emerging cancer immunotherapy. Front Immunol. 2021;12:701006.","journal-title":"Front Immunol"},{"key":"2078_CR13","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1038\/s41467-021-22618-x","volume":"12","author":"Y Huang","year":"2021","unstructured":"Huang Y, Zhang HL, Li ZL, Du T, Chen YH, Wang Y, Ni HH, Zhang KM, Mai J, Hu BX, et al. FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer. Nat Commun. 2021;12:2672.","journal-title":"Nat Commun"},{"key":"2078_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13045-018-0582-8","volume":"11","author":"JA Marin-Acevedo","year":"2018","unstructured":"Marin-Acevedo JA, Dholaria B, Soyano AE, Knutson KL, Chumsri S, Lou Y. Next generation of immune checkpoint therapy in cancer: new developments and challenges. J Hematol Oncol. 2018;11:39.","journal-title":"J Hematol Oncol"},{"key":"2078_CR15","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.7150\/ijbs.41105","volume":"16","author":"S Yang","year":"2020","unstructured":"Yang S, Wei W, Zhao Q. B7\u2013H3, a checkpoint molecule, as a target for cancer immunotherapy. Int J Biol Sci. 2020;16:1767\u201373.","journal-title":"Int J Biol Sci"},{"key":"2078_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ccell.2019.01.002","volume":"35","author":"H Du","year":"2019","unstructured":"Du H, Hirabayashi K, Ahn S, Kren NP, Montgomery SA, Wang X, Tiruthani K, Mirlekar B, Michaud D, Greene K, et al. Antitumor responses in the absence of toxicity in solid tumors by targeting B7\u2013H3 via chimeric antigen receptor T cells. Cancer Cell. 2019;35:221-237.e228.","journal-title":"Cancer Cell"},{"key":"2078_CR17","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1016\/j.wneu.2019.10.044","volume":"135","author":"J Deng","year":"2020","unstructured":"Deng J, Ma M, Wang D, Zhu H, Hua L, Sun S, Chen H, Cheng H, Qian ZR, Xie Q, et al. Expression and clinical significance of immune checkpoint regulator B7\u2013H3 (CD276) in human meningioma. World Neurosurg. 2020;135:e12\u20138.","journal-title":"World Neurosurg"},{"key":"2078_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccell.2017.03.005","volume":"31","author":"S Seaman","year":"2017","unstructured":"Seaman S, Zhu Z, Saha S, Zhang XM, Yang MY, Hilton MB, Morris K, Szot C, Morris H, Swing DA, et al. Eradication of tumors through simultaneous ablation of CD276\/B7-H3-positive tumor cells and tumor vasculature. Cancer Cell. 2017;31:501-515.e508.","journal-title":"Cancer Cell"},{"key":"2078_CR19","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1158\/1078-0432.CCR-20-2584","volume":"27","author":"F Kontos","year":"2021","unstructured":"Kontos F, Michelakos T, Kurokawa T, Sadagopan A, Schwab JH, Ferrone CR, Ferrone S. B7\u2013H3: an attractive target for antibody-based immunotherapy. Clin Cancer Res. 2021;27:1227\u201335.","journal-title":"Clin Cancer Res"},{"key":"2078_CR20","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S1470-2045(18)30322-X","volume":"19","author":"MM Souweidane","year":"2018","unstructured":"Souweidane MM, Kramer K, Pandit-Taskar N, Zhou Z, Haque S, Zanzonico P, Carrasquillo JA, Lyashchenko SK, Thakur SB, Donzelli M, et al. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial. Lancet Oncol. 2018;19:1040\u201350.","journal-title":"Lancet Oncol"},{"key":"2078_CR21","doi-asserted-by":"publisher","first-page":"1900158","DOI":"10.1002\/advs.201900158","volume":"6","author":"Y Chang","year":"2019","unstructured":"Chang Y, Feng Y, Cheng Y, Zheng R, Wu X, Jian H, Zhang D, Tang Z, Wang Z, Hao J, Zhang H. Anisotropic plasmonic metal heterostructures as theranostic nanosystems for near infrared light-activated fluorescence amplification and phototherapy. Adv Sci. 2019;6:1900158.","journal-title":"Adv Sci"},{"key":"2078_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.biomaterials.2016.03.040","volume":"93","author":"EY Chuang","year":"2016","unstructured":"Chuang EY, Lin CC, Chen KJ, Wan DH, Lin KJ, Ho YC, Lin PY, Sung HW. A FRET-guided, NIR-responsive bubble-generating liposomal system for in vivo targeted therapy with spatially and temporally precise controlled release. Biomaterials. 2016;93:48\u201359.","journal-title":"Biomaterials"},{"key":"2078_CR23","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1021\/acs.nanolett.7b04162","volume":"18","author":"Y Chang","year":"2018","unstructured":"Chang Y, Cheng Y, Feng Y, Jian H, Wang L, Ma X, Li X, Zhang H. Resonance energy transfer-promoted photothermal and photodynamic performance of gold-copper sulfide yolk-shell nanoparticles for chemophototherapy of cancer. Nano Lett. 2018;18:886\u201397.","journal-title":"Nano Lett"},{"key":"2078_CR24","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.chest.2020.08.2047","volume":"159","author":"AC Chen","year":"2021","unstructured":"Chen AC, Pastis NJ Jr, Mahajan AK, Khandhar SJ, Simoff MJ, Machuzak MS, Cicenia J, Gildea TR, Silvestri GA. Robotic bronchoscopy for peripheral pulmonary lesions: a multicenter pilot and feasibility study (BENEFIT). Chest. 2021;159:845\u201352.","journal-title":"Chest"},{"key":"2078_CR25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jtho.2018.11.013","volume":"14","author":"EE Folch","year":"2019","unstructured":"Folch EE, Pritchett MA, Nead MA, Bowling MR, Murgu SD, Krimsky WS, Murillo BA, LeMense GP, Minnich DJ, Bansal S, et al. electromagnetic navigation bronchoscopy for peripheral pulmonary lesions: one-year results of the prospective, multicenter NAVIGATE study. J Thorac Oncol. 2019;14:445\u201358.","journal-title":"J Thorac Oncol"},{"key":"2078_CR26","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.7150\/thno.27631","volume":"8","author":"Q Xu","year":"2018","unstructured":"Xu Q, Wan J, Bie N, Song X, Yang X, Yong T, Zhao Y, Yang X, Gan L. A biomimetic gold nanocages-based nanoplatform for efficient tumor ablation and reduced inflammation. Theranostics. 2018;8:5362\u201378.","journal-title":"Theranostics"},{"key":"2078_CR27","doi-asserted-by":"publisher","first-page":"e202112925","DOI":"10.1002\/anie.202112925","volume":"61","author":"F Zeng","year":"2022","unstructured":"Zeng F, Tang L, Zhang Q, Shi C, Huang Z, Nijiati S, Chen X, Zhou Z. Coordinating the mechanisms of action of ferroptosis and the photothermal effect for cancer theranostics. Angew Chem Int Ed Engl. 2022;61:e202112925.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2078_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nnano.2015.342","volume":"11","author":"Y Matsumoto","year":"2016","unstructured":"Matsumoto Y, Nichols JW, Toh K, Nomoto T, Cabral H, Miura Y, Christie RJ, Yamada N, Ogura T, Kano MR, et al. Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery. Nat Nanotechnol. 2016;11:533\u20138.","journal-title":"Nat Nanotechnol"},{"key":"2078_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.addr.2016.04.025","volume":"108","author":"JI Hare","year":"2017","unstructured":"Hare JI, Lammers T, Ashford MB, Puri S, Storm G, Barry ST. Challenges and strategies in anti-cancer nanomedicine development: an industry perspective. Adv Drug Deliv Rev. 2017;108:25\u201338.","journal-title":"Adv Drug Deliv Rev"},{"key":"2078_CR30","doi-asserted-by":"publisher","first-page":"e2201971","DOI":"10.1002\/smll.202201971","volume":"18","author":"B Xie","year":"2022","unstructured":"Xie B, Zhao H, Shui M, Ding YF, Sun C, Wang Z, Gao C, Chen G, Wang R. Spermine-responsive intracellular self-aggregation of gold nanocages for enhanced chemotherapy and photothermal therapy of breast cancer. Small. 2022;18:e2201971.","journal-title":"Small"},{"key":"2078_CR31","doi-asserted-by":"publisher","first-page":"119327","DOI":"10.1016\/j.biomaterials.2019.119327","volume":"217","author":"Y Feng","year":"2019","unstructured":"Feng Y, Cheng Y, Chang Y, Jian H, Zheng R, Wu X, Xu K, Wang L, Ma X, Li X, Zhang H. Time-staggered delivery of erlotinib and doxorubicin by gold nanocages with two smart polymers for reprogrammable release and synergistic with photothermal therapy. Biomaterials. 2019;217:119327.","journal-title":"Biomaterials"},{"key":"2078_CR32","doi-asserted-by":"publisher","first-page":"141603","DOI":"10.1016\/j.cej.2023.141603","volume":"459","author":"CG Yu","year":"2023","unstructured":"Yu CG, Lv YJ, Li XD, Bao HY, Cao XL, Huang J, Zhang ZJ. SOD-Functionalized gold nanoparticles as ROS scavenger and CT contrast agent for protection and imaging tracking of mesenchymal stem cells in Idiopathic pulmonary fibrosis treatment. Chem Eng J. 2023;459:141603.","journal-title":"Chem Eng J"},{"key":"2078_CR33","doi-asserted-by":"publisher","first-page":"136868","DOI":"10.1016\/j.cej.2022.136868","volume":"446","author":"R Venkatesan","year":"2022","unstructured":"Venkatesan R, Xiong H, Yao YJ, Nakkala JR, Zhou T, Li SF, Fan CY, Gao CY. Immuno-modulating theranostic gold nanocages for the treatment of rheumatoid arthritis in vivo. Chem Eng J. 2022;446:136868.","journal-title":"Chem Eng J"},{"key":"2078_CR34","doi-asserted-by":"publisher","first-page":"154105","DOI":"10.1016\/j.phymed.2022.154105","volume":"101","author":"S Li","year":"2022","unstructured":"Li S, Liu H, Lin Z, Li Z, Chen Y, Chen B, Huang L, Lin X, Yao H. Isoorientin attenuates doxorubicin-induced cardiac injury via the activation of MAPK, Akt, and Caspase-dependent signaling pathways. Phytomedicine. 2022;101:154105.","journal-title":"Phytomedicine"},{"key":"2078_CR35","first-page":"9175","volume":"13","author":"L Bo","year":"2021","unstructured":"Bo L, Shi L, Jin F, Li C. The hemorrhage risk of patients undergoing bronchoscopic examinations or treatments. Am J Transl Res. 2021;13:9175\u201381.","journal-title":"Am J Transl Res"},{"key":"2078_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12951-020-00754-8","volume":"19","author":"B Gong","year":"2021","unstructured":"Gong B, Shen Y, Li H, Li X, Huan X, Zhou J, Chen Y, Wu J, Li W. Thermo-responsive polymer encapsulated gold nanorods for single continuous wave laser-induced photodynamic\/photothermal tumour therapy. J Nanobiotechnol. 2021;19:41.","journal-title":"J Nanobiotechnol"},{"key":"2078_CR37","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1007\/s12274-017-1963-y","volume":"11","author":"DY Wu","year":"2018","unstructured":"Wu DY, Wang HS, Hou XS, Chen H, Ma Y, Hou YL, Hong J, Ding Y. Effects of gold core size on regulating the performance of doxorubicin-conjugated gold nanoparticles. Nano Res. 2018;11:3396\u2013410.","journal-title":"Nano Res"},{"key":"2078_CR38","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1513\/AnnalsATS.202109-1071OC","volume":"19","author":"X Zheng","year":"2022","unstructured":"Zheng X, Cao L, Zhang Y, Xie F, Yang H, Liu J, Qu S, Zhang J, Sun J. A novel electromagnetic navigation bronchoscopy system for the diagnosis of peripheral pulmonary nodules: a randomized clinical trial. Ann Am Thorac Soc. 2022;19:1730\u20139.","journal-title":"Ann Am Thorac Soc"},{"key":"2078_CR39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.1238856","volume":"341","author":"K Weiskopf","year":"2013","unstructured":"Weiskopf K, Ring AM, Ho CC, Volkmer JP, Levin AM, Volkmer AK, Ozkan E, Fernhoff NB, van de Rijn M, Weissman IL, Garcia KC. Engineered SIRP\u03b1 variants as immunotherapeutic adjuvants to anticancer antibodies. Science. 2013;341:88\u201391.","journal-title":"Science"},{"key":"2078_CR40","doi-asserted-by":"publisher","first-page":"8569","DOI":"10.1021\/acsami.6b16669","volume":"9","author":"T Cui","year":"2017","unstructured":"Cui T, Liang JJ, Chen H, Geng DD, Jiao L, Yang JY, Qian H, Zhang C, Ding Y. Performance of doxorubicin-conjugated gold nanoparticles: regulation of drug location. ACS Appl Mater Interfaces. 2017;9:8569\u201380.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2078_CR41","doi-asserted-by":"publisher","first-page":"e2205532","DOI":"10.1002\/advs.202205532","volume":"10","author":"C Huang","year":"2023","unstructured":"Huang C, Duan X, Wang J, Tian Q, Ren Y, Chen K, Zhang Z, Li Y, Feng Y, Zhong K, et al. Lipid nanoparticle delivery system for mRNA encoding B7H3-redirected bispecific antibody displays potent antitumor effects on malignant tumors. Adv Sci. 2023;10:e2205532.","journal-title":"Adv Sci"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-02078-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-02078-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-02078-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T07:23:27Z","timestamp":1700378607000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-02078-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2078"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-02078-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3000523\/v1","asserted-by":"object"}]},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"assertion":[{"value":"30 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the animal experiments were approved by the Experimental Animal Center of Fujian Medical University. Animal experiments were carried out in compliance with the Guide for the Animals Care and Ethics Committee of Fujian Medical University (Certificate number: FJMU IACUC 2021-0339).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"378"}}